894 resultados para Bigelow-Sanford Carpet Company, inc.


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Objectives: To estimate prevalence, age-of-onset, gender distribution and identify correlates of lifetime psychiatric disorders in the Sao Paulo Metropolitan Area (SPMA). Methods: The Sao Paulo Megacity Mental Health Survey assessed psychiatric disorders on a probabilistic sample of 5,037 adult residents in the SPMA, using the World Mental Health Survey Version of the Composite International Diagnostic Interview. Response rate was 81.3%. Results: Lifetime prevalence for any disorder was 44.8%; estimated risk at age 75 was 57.7%; comorbidity was frequent. Major depression, specific phobias and alcohol abuse were the most prevalent across disorders; anxiety disorders were the most frequent class. Early age-of-onset for phobic and impulse-control disorders and later age-of-onset for mood disorders were observed. Women were more likely to have anxiety and mood disorders, whereas men, substance use disorders. Apart from conduct disorders, more frequent in men, there were no gender differences in impulse-control disorders. There was a consistent trend of higher prevalence in the youngest cohorts. Low education level was associated to substance use disorders. Conclusions: Psychiatric disorders are highly prevalent among the general adult population in the SPMA, with frequent comorbidity, early age-of-onset for most disorders, and younger cohorts presenting higher rates of morbidity. Such scenario calls for vigorous public health action.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Background In ROCKET AF, rivaroxaban was non-inferior to adjusted-dose warfarin in preventing stroke or systemic embolism among patients with atrial fibrillation (AF). We aimed to investigate whether the efficacy and safety of rivaroxaban compared with warfarin is consistent among the subgroups of patients with and without previous stroke or transient ischaemic attack (TIA). Methods In ROCKET AF, patients with AF who were at increased risk of stroke were randomly assigned (1:1) in a double-blind manner to rivaroxaban 20 mg daily or adjusted dose warfarin (international normalised ratio 2-0-3.0). Patients and investigators were masked to treatment allocation. Between Dec 18,2006, and June 17,2009,14 264 patients from 1178 centres in 45 countries were randomly assigned. The primary endpoint was the composite of stroke or non-CNS systemic embolism. In this substudy we assessed the interaction of the treatment effects of rivaroxaban and warfarin among patients with and without previous stroke or TIA. Efficacy analyses were by intention to treat and safety analyses were done in the on-treatment population. ROCKET AF is registered with ClinicalTrials.gov, number NCT00403767. Findings 7468 (52%) patients had a previous stroke (n=4907) or TIA (n=2561) and 6796 (48%) had no previous stroke or TIA. The number of events per 100 person-years for the primary endpoint in patients treated with rivaroxaban compared with warfarin was consistent among patients with previous stroke or TIA (2.79% rivaroxaban vs 2.96% warfarin; hazard ratio [HR] 0-94,95% CI 0.77-1.16) and those without (1.44% vs 1.88%; 0.77, 0.58-1-01; interaction p=0.23). The number of major and non-major clinically relevant bleeding events per 100 person-years in patients treated with rivaroxaban compared with warfarin was consistent among patients with previous stroke or TIA (13.31% rivaroxaban vs 13.87% warfarin; HR 0.96,95% CI 0.87-1-07) and those without (16.69% vs 15.19%; 1.10, 0.99-1.21; interaction p=0.08). Interpretation There was no evidence that the relative efficacy and safety of rivaroxaban compared with warfarin was different between patients who had a previous stroke or TIA and those who had no previous stroke or TIA. These results support the use of rivaroxaban as an alternative to warfarin for prevention of recurrent as well as initial stroke in patients with AF.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The study aims to analyze the IT architecture management practices associated with their degree of maturity and the influence of institutional and strategic factors on the decisions involved through a case study in a large telecom organization. The case study allowed us to identify practices that led the company to its current stage of maturity and identify practices that can lead the company to the next stage. The strategic influence was mentioned by most respondents and the institutional influence was present in decisions related to innovation and those dealing with a higher level of uncertainties.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Grazie all’analisi del dibattito in corso nelle istituzioni europee inerente il tema della neutralità della rete si è avuto modo di capire come le web companies, debbano non solo interagire con il proprio mercato, ma anche con un ambiente in cui vi sono attori che definiscono regole ed influenzano i contesti sociali. Questo ambiente è composto da quei fattori sociali, politici e legali che interagiscono e influenzano dall’esterno i mercati e gli accordi privati. Esso comprende quindi tutte le interazioni economiche che hanno come intermediario un soggetto pubblico, in questo caso le istituzioni europee, e in cui, causa questa presenza, la natura degli accordi non risponde prettamente a logiche economiche ma più a quelle politiche.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Tesi rivolta allo studio del comportamento di Google Inc. nel campo delle lobby, in America ed in Europa: quanto investe nell'attività di lobbying, quali leggi vuole far approvare, perché è interessata a quel disegno di legge, differenze tra lobby americane ed europee e difficoltà incontrate in Europa.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

http://digitalcommons.bucknell.edu/dance_performances/1029/thumbnail.jpg

Relevância:

20.00% 20.00%

Publicador:

Resumo:

http://digitalcommons.bucknell.edu/dance_performances/1028/thumbnail.jpg